Prof. Dr. EMİN KAYA

Yayın Ağı

Makaleler 148

1. Can polycythaemia vera disease be predicted from haematologic parameters? A machine learning-based study

HASKUL M., KAYA E., Kurtoäÿlu A.

Journal of Clinical Pathology , cilt.78, sa.10, ss.684-690, 2025 (SCI-Expanded)

2. When should I use filgrastim after autologous transplantation in MM patients?

Arslan S., Berber I., Kuku I., KAYA E., Erkurt M. A., Biçim S., et al.

Transfusion and Apheresis Science , cilt.64, sa.4, 2025 (SCI-Expanded)

3. The role of heparin in autologous stem cell mobilization in patients with multiple myeloma

SARICI A., ERKURT M. A., Yilmaz S., Demircioglu S., BERBER İ., Basturk A., et al.

Transfusion and Apheresis Science , cilt.64, sa.4, 2025 (SCI-Expanded)

4. The impact of second allogeneic hematopoietic stem cell transplantation as salvage therapy for hematologic diseases after a first allogeneic transplantation

BATGİ H., Zorlu T., ERKURT M. A., UZAY A., Hindilerden I. Y., Pepeler M. S., et al.

Transfusion and Apheresis Science , cilt.64, sa.4, 2025 (SCI-Expanded)

5. What should be the optimal dose of post-transplantation cyclophosphamide for GVHD prophylaxis in allogeneic stem cell transplantation?

Ulas T., NAMDAROĞLU S., Hindilerden I. Y., ERKURT M. A., Erer K., Yigenoglu T. N., et al.

Transfusion and Apheresis Science , cilt.64, sa.1, 2025 (SCI-Expanded)

6. What is the role of alpha-1 antitrypsin in the management of acute graft versus host disease?

Yigenoglu T. N., ERKURT M. A., Dagdas S., Ulu B. U., KUKU İ., Durdu A., et al.

Transfusion and Apheresis Science , cilt.64, sa.1, 2025 (SCI-Expanded)

7. Relationship between reticular fibrosis with platelet surface markers (CD41A, CD42A, CD42B, CD61) and prognostic markers (WBC, PLT) in acute promyelocytic leukemia

KAYA A., ERKURT M. A., KUKU İ., KAYA E., BERBER İ., SARICI A., et al.

ACTA HAEMATOLOGICA POLONICA , cilt.55, 2024 (Scopus)

8. Effects of extracorporeal photopheresis on survival in chronic graft versus host disease

KAYA A., ERKURT M. A., KUKU İ., KAYA E., BERBER İ., BİÇİM S., et al.

MARMARA MEDICAL JOURNAL , cilt.37, 2024 (ESCI)

9. The role of therapeutic plasma exchange in the treatment of patients with septic shock- single center experience

Çelik S., ERKURT M. A., SARICI A., KUKU İ., KAYA E., BERBER İ., et al.

Journal of Current Hematology &amp; Oncology Research , cilt.2, 2024 (Hakemli Dergi)

10. Prophylactic intravenous immunoglobulin use in allogeneic stem cell transplantation; does intravenous immunoglobulin affect survival, sepsis, and engraftment time?

KAYA A., BERBER İ., KAYA E., ERKURT M. A., BİÇİM S., ARSLAN S., et al.

IRAQI JOURNAL OF HEMATOLOGY , cilt.13, 2024 (ESCI)

11. Retrospective evaluation of indications for therapeutic plasmapheresis procedures applied in our center

ERYILDIZ S., KUKU İ., KAYA E., ERKURT M. A., BERBER İ.

Journal of Current Hematology &amp; Oncology Research , cilt.2, 2024 (Hakemli Dergi)

12. Evaluation of busulfan, cyclophosphamide, and etoposide as a preparation regimen for autologous stem cell transplantation in Hodgkin’s lymphoma patients

BİÇİM S., ERKURT M. A., KUKU İ., KAYA E., BERBER İ., KAYA A., et al.

IRAQI JOURNAL OF HEMATOLOGY , cilt.13, 2024 (ESCI)

13. How are the Results of Allogeneic Stem Cell Transplantation in Elderly Patients? A Single-center Experience

Uysal A., ERKURT M. A., KUKU I., Kaya E., BERBER I., SARICI A., et al.

ACTA ONCOLOGICA TURCICA , cilt.56, sa.2, ss.106-113, 2023 (Hakemli Dergi)

14. The Experience of Ibrutinib in Chronic Graft-Versus-Host Disease in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: Single Center Experience

Sarıcı A., Erkurt M. A., Kuku İ., Kaya E., Berber İ., Biçim S., et al.

İstanbul Medical Journal , cilt.24, sa.2, ss.216-220, 2023 (Hakemli Dergi)

15. The effect of CD 34+ stem cell dose on both short-term and long-term outcomes of autologous stem cell transplantation in multiple myeloma

UYSAL A., ERKURT M. A., KUKU İ., KAYA E., BERBER İ., SARICI A., et al.

Annals of Medical Research , cilt.30, sa.3, ss.331-336, 2023 (Hakemli Dergi)

16. Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients with Thalassemia: A Single-Center Experience and Literature Review

UYSAL A., ERKURT M. A., SARICI A., KUKU İ., BİÇİM S., HİDAYET E., et al.

Fırat Tıp Dergisi , cilt.28, sa.1, ss.46-50, 2023 (Hakemli Dergi)

17. A case of malignant melanoma presented with lombar vertebra fracture

SARICI A., KUKU İ., BERBER İ., ERKURT M. A., ER ULUBABA H., BİÇİM S., et al.

Journal of Current Hematology & Oncology Research , cilt.1, 2023 (Hakemli Dergi)

18. Effect of tyrosine kinase inhibitor and conventional chemotherapy on COVID 19 antibody level in hematological patients

KAYA A., BERBER İ., KUKU İ., ÇELİK S., KAYA E., BİÇİM S., et al.

Journal of Current Hematology & Oncology Research , cilt.1, 2023 (Hakemli Dergi)

19. The effect of preemptive use of plerixafor on stem cell mobilization in patients with lymphoma and multiple myeloma

UYSAL A., ERKURT M. A., KUKU İ., KAYA E., BERBER İ., SARICI A., et al.

MARMARA MEDICAL JOURNAL , cilt.36, 2023 (ESCI)

20. Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients with Thalassemia: A Single-Center Experience and Literature Review

Uysal A., Erkurt M. A., Sarıcı A., Kuku İ., Biçim S., Hidayet E., et al.

Fırat Tıp Dergisi , cilt.28, sa.1, ss.46-50, 2023 (Hakemli Dergi)

21. The frequency of HLA A, B, C, DP, DQ, DR allele in patients of Turkish and Syrian nationals with allogeneic stem cell transplantation

KAYA A., ERKURT M. A., KUKU İ., KAYA E., BERBER İ., BİÇİM S., et al.

IRAQI JOURNAL OF HEMATOLOGY , cilt.11, sa.2, ss.110-117, 2022 (Hakemli Dergi)

22. Effects Of Ethnicity On Allogenic Stem Cell Mobilization

KAYA A., ERKURT M. A., KUKU İ., KAYA E., BERBER İ., SARICI A., et al.

International Journal of Clinical Images and Medical Reviews , cilt.2, sa.2, ss.1-4, 2022 (Hakemli Dergi)

23. Convalescent plasma therapy in COVID-19

UYSAL A., ERKURT M. A., KUKU İ., SARICI A., BİÇİM S., KAYA E., et al.

Medicine Science , cilt.11, sa.2, ss.920-923, 2022 (Hakemli Dergi)

24. The effect of comorbidity on survival and collected CD34+cell counts in autologous hematopoietic stem cell transplant patients

SARICI A., ERKURT M. A., KUKU İ., Bahcecioglu O. F., Bicim S., KAYA E., et al.

TRANSFUSION AND APHERESIS SCIENCE , cilt.61, sa.1, 2022 (SCI-Expanded)

25. The Prophylactic Treatment of COVID-19 in a Renal Failure and Hodgkin Lymphoma Patient with Convalescent Plasma

BİÇİM S., BERBER İ., ERKURT M. A., KUKU İ., KAYA E., BİLGİÇ Y., et al.

International Journal of Research and Reports in Hematology , cilt.5, sa.2, ss.1-5, 2022 (Hakemli Dergi)

26. Predictive Significance of Mean Platelet Volume and Platelet Distribution Width Level in Immune Thrombocytopenia Patients Treated With Steroids

KAYA A., KUKU İ., ERKURT M. A., KAYA E., BERBER İ., SARICI A., et al.

International Journal of Research and Reports in Hematology , cilt.5, sa.1, ss.27-33, 2022 (Hakemli Dergi)

27. Non-infectious Complications in Patients with Allogeneic Hematopoietic Stem Cell Transplantation- Single Center Experience from Eastern Anatolia

KARAMAN S., SARICI A., ERKURT M. A., BİÇİM S., HİDAYET E., KAYA A., et al.

ACTA ONCOLOGICA TURCICA , cilt.55, 2022 (Hakemli Dergi)

28. Cardiac autonomic control during platelet apheresis

CAKAN P., OZGUL M., ERKUT M. A., KAYA E., YILDIZ S., KUKU İ.

Annals of Medical Research , cilt.29, sa.3, ss.203-210, 2022 (Hakemli Dergi)

29. The effect of vitamin d and parathyroid hormone level on the number of cd 34 stem cells after mobilization regime in patients with multiple myelom and non hodgkin lymphoma

KAYA A., KAYA E., ERKURT M. A., KUKU İ.

International Journal of Clinical Images and Medical Reviews , cilt.1, sa.1, ss.1-3, 2022 (Hakemli Dergi)

30. The effect of cryopreserved and noncryopreserved stem cells on the outcome of autologous stem-cell transplantation in multiple myeloma patients: A single-center experience

UYSAL A., ERKURT M. A., KUKU İ., KAYA E., BERBER İ., SARICI A., et al.

EGYPTIAN JOURNAL OF HAEMATOLOGY , cilt.47, 2022 (Hakemli Dergi)

31. Etiological evaluation and the role of plasma exchange treatment in trombotic microangiopathies: A retrospective analysis from Eastern Anatolia

HİDAYET E., ERKURT M. A., SARICI A., KUKU İ., BERBER İ., KAYA E., et al.

Medicine Science , cilt.11, 2022 (Hakemli Dergi)

32. Pas III Added Donor Platelet Suspensions on Platelet Count Ph and Allergic Transfusion Reactions

Özgül M., KUKU İ., ERKURT M. A., SARICI A., BİÇİM S., BERBER İ., et al.

International Journal of Research and Reports in Hematology , cilt.4, sa.2, 2021 (Hakemli Dergi)

33. Life saving effect of early use of convalescent plasma in Covid-19 treatment

SARICI A., ERKURT M. A., KUKU İ., BİÇİM S., BERBER İ., KAYA E., et al.

Annals of Medical Research , cilt.28, sa.12, ss.2242-2247, 2021 (Hakemli Dergi)

34. Efficacy and safety of ruxolitinib plus extracorporeal photopheresis in acute and chronic graft versus host disease: A single center experience

Sarıcı A., Erkurt M. A., Bahçecioğlu Ö. F., Tanriverdi L. H., Berber İ., Kaya E., et al.

Annals of Medical Research , cilt.28, sa.11, ss.2065-2070, 2021 (Hakemli Dergi)

35. Selection of the mobilization regimen in lymphoma patients: A retrospective cohort study

SARICI A., ERKURT M. A., KUKU İ., Gok S., Bahcecioglu O. F., Bicim S., et al.

TRANSFUSION AND APHERESIS SCIENCE , cilt.60, sa.5, 2021 (SCI-Expanded)

36. An innovation in stem cell harvesting: Heparin use

GÜL H. G., ERKURT M. A., SARICI A., KUKU İ., KAYA E., BERBER İ., et al.

TRANSFUSION AND APHERESIS SCIENCE , cilt.60, sa.5, 2021 (SCI-Expanded)

37. Therapeutic plasma exchange for envenomation: Is it reasonable?

BERBER İ., Korkmaz S., SARICI A., ERKURT M. A., KUKU İ., KAYA E., et al.

TRANSFUSION AND APHERESIS SCIENCE , cilt.60, sa.5, 2021 (SCI-Expanded)

38. Extracorporeal photopheresis in steroid-refractory chronic graft-versus-host disease: A retrospective multicenter study

Dal Sinan M., Batgi H., ERKURT M. A., Hindilerden I. Y., KUKU İ., Kurtoglu E., et al.

TRANSFUSION AND APHERESIS SCIENCE , cilt.60, sa.5, 2021 (SCI-Expanded)

39. Early therapeutic plasma exchange may improve treatment outcomes in severe acute toxic Hepatitis

BERBER İ., Cagin Y. F., ERDOĞAN M. A., Ataman E., GÖZÜKARA BAĞ H. G., ERKURT M. A., et al.

TRANSFUSION AND APHERESIS SCIENCE , cilt.60, sa.5, 2021 (SCI-Expanded) Sürdürülebilir Kalkınma

40. The effect of therapeutic plasma exchange on management of HELLP Syndrome: The report of 47 patients

ERKURT M. A., SARICI A., KUKU İ., BERBER İ., KAYA E., Bicim S., et al.

TRANSFUSION AND APHERESIS SCIENCE , cilt.60, sa.5, 2021 (SCI-Expanded)

41. Extracorporeal photopheresis in the treatment of acute graft-versus-host disease: A multicenter experience

Batgi H., Dal M. S., ERKURT M. A., KUKU İ., Kurtoglu E., Hindilerden I. Y., et al.

TRANSFUSION AND APHERESIS SCIENCE , cilt.60, sa.5, 2021 (SCI-Expanded)

42. Filgrastim alone versus cyclophosphamide and filgrastim for mobilization in multiple myeloma patients

SARICI A., ERKURT M. A., Bahcecioglu O. F., Gok S., KUKU İ., Bicim S., et al.

TRANSFUSION AND APHERESIS SCIENCE , cilt.60, sa.4, 2021 (SCI-Expanded)

43. Lenograstim versus filgrastim in mobilization before autologous hematopoietic stem cell transplantation in patients with multiple myeloma and lymphoma-Single center experience

SARICI A., ERKURT M. A., Bahcecioglu O. F., Bicim S., BERBER İ., Gok S., et al.

TRANSFUSION AND APHERESIS SCIENCE , cilt.60, sa.4, 2021 (SCI-Expanded)

44. FLAMSA vs BU-FLU in patients undergoing allogeneic stem cell transplantation for acute leukemia and myelodysplastic syndrome

SARICI A., ERKURT M. A., KUKU İ., Gök S., Bahçecioğlu Ö. F., BİÇİM S., et al.

Medical Science and Discovery , cilt.8, sa.6, ss.356-360, 2021 (Hakemli Dergi)

45. Experience of ibrutinib in a patient with recurrent mantle cell lymphoma with orbital involvement

SARICI A., KUKU İ., KAYA E., ERKURT M. A., BERBER İ., BİÇİM S., et al.

Medicine Science , cilt.10, sa.4, ss.1542-1545, 2021 (Hakemli Dergi)

46. Evaluation of clinical characteristics of patients with paroxysmal nocturnal hemoglobinuria treated with eculizumab in Turkey: a multicenter retrospective analysis

KEKLİK KARADAĞ F., YENEREL M. N., Yılmaz M., ÜSKÜDAR TEKE H., ÖZKOCAMAN V., Tuglular T. F., et al.

AMERICAN JOURNAL OF BLOOD RESEARCH , cilt.11, sa.3, ss.271-278, 2021 (ESCI)

47. Comparison of efficacy and toxicity of treosulfan-fludarabine and busulfan-cyclophosphamide conditioning regimens in patients undergoing allogeneic stem cell transplantation

SARICI A., ERKURT M. A., KUKU İ., BAHÇECİOĞLU Ö. F., GÖK S., BİÇİM S., et al.

Medicine Science , cilt.10, sa.4, ss.1133-1137, 2021 (Hakemli Dergi)

48. BK virus incidence, risk factors and its effect on mortality in hematopoietic stem cell transplant patients-single center experience

DEVİREN M. V., SARICI A., ERKURT M. A., BAHÇECİOĞLU Ö. F., BİÇİM S., BERBER İ., et al.

Medicine Science , cilt.10, sa.3, ss.856-859, 2021 (Hakemli Dergi)

49. Successful treatment with convalescent plasma in Covid-19 disease in relaps/refractory multiple myeloma

SARICI A., BİÇİM S., ERKURT M. A., BERBER İ., KAYA E., KUKU İ., et al.

Annals of Medical Research , cilt.28, sa.12, ss.2239-2241, 2021 (Hakemli Dergi) Sürdürülebilir Kalkınma

50. Efficacy and Safety of Ibrutinib Therapy in Patients with Chronic Lymphocytic Leukemia: Retrospective Analysis of Real-Life Data

TOMBAK A., Tanrikulu F. P., Durusoy S. S., DİNÇYÜREK H. D., KAYA E., ÜMİT E. G., et al.

TURKISH JOURNAL OF HEMATOLOGY , cilt.38, sa.4, ss.273-285, 2021 (SCI-Expanded)

51. Comparison of the renal response of bortezomib-based induction and conventional regimen in multiple myeloma patients with renal failure

SARICI A., KAYA E., ERKURT M. A., BERBER İ., TANRİVERDİ L. H., bahçecioğlu ö. f., et al.

Annals of Medical Research , cilt.28, sa.10, ss.1824-1829, 2021 (Hakemli Dergi)

52. LONG-TERM FOLLOW-UP RESULTS OF NEWLY DIAGNOSED, UNTREATED ADULT PRIMARY IMMUNE THROMBOCYTOPENIA PATIENTS IN TURKEY

Aski V., Ilhami B., Ahmet S., Ali E. M., KAYA E., Irfan K.

ACTA MEDICA MEDITERRANEA , cilt.37, sa.6, ss.3075-3079, 2021 (SCI-Expanded)

53. Life-saving effect of convalescent plasma treatment in covid-19 disease: Clinical trial from eastern Anatolia

ERKURT M. A., SARICI A., BERBER İ., KUKU İ., KAYA E., Ozgul M.

TRANSFUSION AND APHERESIS SCIENCE , cilt.59, sa.5, 2020 (SCI-Expanded) Sürdürülebilir Kalkınma

54. Türkiye’xxnin doğusunda non-Hodgkin lenfoma hastalarının klinik ve patolojik özellikleri

DOGAN A., YILDIRIM D. N., ERKURT M. A., EKİNCİ Ö., KUKU İ., KAYA E.

CUKUROVA MEDICAL JOURNAL , cilt.45, sa.2, ss.533-540, 2020 (ESCI)

55. Clinical and pathological characteristics of patients with non-Hodgkin lymphoma cases in Eastern Turkey

Dogan A., Dogan N. Y., ERKURT M. A., Ekinci O., KUKU İ., KAYA E.

CUKUROVA MEDICAL JOURNAL , cilt.45, sa.2, ss.533-540, 2020 (ESCI)

56. Study for the Diagnostic Screening of Paroxysmal Nocturnal Hemoglobinuria in Older Patients with Unexplained Anemia and/or Cytopenia

Ozdemir Z. N., İLHAN O., Ozet G., Falay M., Yenerel M., Tuglular T., et al.

CLINICAL LABORATORY , cilt.66, sa.9, ss.1709-1715, 2020 (SCI-Expanded)

57. Study for the diagnostic screening of paroxsymal nocturnal hemoglobinuria in Turkey: Prospective multicentric evaluation of suspected patients

Ilhan O., Ozdemir Z. N., Ozet G., Falay M., Yenerel M., Tuglular T., et al.

TRANSFUSION AND APHERESIS SCIENCE , cilt.58, sa.5, ss.659-662, 2019 (SCI-Expanded)

58. Evaluation of the JAK2 V617F gene mutation in myeloproliferative neoplasms cases: a one-center study from Eastern Anatolia

Gülbay G., YEŞİLADA E., ERKURT M. A., BAG H. G., KUKU İ., KAYA E.

TURKISH JOURNAL OF BIOCHEMISTRY-TURK BIYOKIMYA DERGISI , cilt.44, sa.4, ss.492-498, 2019 (SCI-Expanded)

59. Repeat Ultrasonographic Examinations Reveal Accessory Spleen in a Case with Relapse ITP

SARICI A., SLOCUM A., ULUBABA H. E., KANDEMİR M. H., ERKURT M. A., KAYA E., et al.

International Journal of Blood Research and Disorders , cilt.6, sa.1, ss.1-3, 2019 (Hakemli Dergi)

60. A Multi-Center Study on the Efficacy of Eltrombopag in Management of Refractory Chronic Immune Thrombocytopenia: A Real-Life Experience

Cekdemir D., Guvenc S., Ozdemirkiran F., Eser A., Topts T., Ozkocaman V., et al.

TURKISH JOURNAL OF HEMATOLOGY , cilt.36, sa.4, ss.230-237, 2019 (SCI-Expanded)

61. Repeat ultrasonographic examinations reveal accessory spleen in case with relapse ITP

SARICI A., SLOCUM A., ER ULUBABA H., KANDEMİR M. H., ERKURT M. A., KAYA E., et al.

International journal of blood research and disorders , cilt.6, sa.1, ss.1-3, 2019 (Hakemli Dergi)

62. YAŞLI HASTADA HODGKİN LENFOMA

KAYA E.

Türkiye Klinikleri Hematoloji , cilt.11, sa.3, ss.48-51, 2018 (Hakemli Dergi)

63. Stem cell mobilization kinetics in elderly patients with multiple myeloma

Dogu M. H., Batgi H., ERKURT M. A., Hacioglu S., Tekgunduz E., KAYA E., et al.

TRANSFUSION AND APHERESIS SCIENCE , cilt.57, sa.2, ss.204-207, 2018 (SCI-Expanded)

64. A multicenter experience of thrombotic microangiopathies in Turkey: The Turkish Hematology Research and Education Group (ThREG)-TMA01 study

Tekgunduz E., YILMAZ M., ERKURT M. A., KİKİ İ., Kaya A. H., KAYNAR L., et al.

TRANSFUSION AND APHERESIS SCIENCE , cilt.57, sa.1, ss.27-30, 2018 (SCI-Expanded)

65. Clinical Characteristics and Treatments Outcomes in Elderly Patients with Multiple Myeloma: A Multicenter Retrospective Study

TERZİ H., KORKMAZ S., BERBER İ., KEKLİK M., DOĞU M. H., ŞENCAN M., et al.

Cumhuriyet Medical Journal , cilt.39, sa.1, ss.389-395, 2017 (Hakemli Dergi)

66. Multicenter Retrospective Analysis of Turkish Patients with Chronic Myeloproliferative Neoplasms

SOYER N., HAZNEDAROĞLU İ. C., Comert M., Cekdemir D., YILMAZ M., ÜNAL A., et al.

TURKISH JOURNAL OF HEMATOLOGY , cilt.34, sa.1, ss.27-33, 2017 (SCI-Expanded)

67. Assessing Safety of Pneumatic Tube System (PTS) for Patients with Very Low Hematologic Parameters

Koroglu M., ERKURT M. A., KUKU İ., KAYA E., Berber İ., Nizam I., et al.

MEDICAL SCIENCE MONITOR , cilt.22, ss.1329-1333, 2016 (SCI-Expanded)

68. Does the preference of peripheral versus central venous access in peripheral blood stem cell collection/yield change stem cell kinetics in autologous stem cell transplantation?

Dogu M. H., KAYA E., Berber İ., SARI İ., Tekgunduz E., ERKURT M. A., et al.

TRANSFUSION AND APHERESIS SCIENCE , cilt.54, sa.1, ss.76-79, 2016 (SCI-Expanded)

69. DHAP plus filgrastim as an effective peripheral stem cell mobilization regimen for autologous stem-cell transplantation in patients with relapsed/refractory lymphoma: A single center experience

BERBER İ., ERKURT M. A., KUKU İ., Maya E., Bag H. G., NIZAM I., et al.

TRANSFUSION AND APHERESIS SCIENCE , cilt.54, sa.1, ss.48-52, 2016 (SCI-Expanded)

70. Primary central nervous system lymphoma in daily practice and the role of autologous stem cell transplantation in relapsed disease: A retrospective multicenter study

ERKURT M. A., Berber İ., Tekgunduz E., Dogu M. H., Korkmaz S., Demir C., et al.

TRANSFUSION AND APHERESIS SCIENCE , cilt.54, sa.1, ss.80-84, 2016 (SCI-Expanded)

71. Leukapheresis Treatment in Elderly Acute Leukemia Patients with Hyperleukocytosis: A Single Center Experience

BERBER İ., ERKURT M. A., KUKU İ., KAYA E., Bag H. G., NIZAM I., et al.

JOURNAL OF CLINICAL APHERESIS , cilt.31, sa.1, ss.53-58, 2016 (SCI-Expanded)

72. Leukapheresis in acute myeloid leukemia patients with hyperleukocytosis: A single center experience

BERBER İ., KUKU İ., ERKURT M. A., KAYA E., Bag H. G., NIZAM I., et al.

TRANSFUSION AND APHERESIS SCIENCE , cilt.53, sa.2, ss.185-190, 2015 (SCI-Expanded)

73. A life-saving therapy in Class I HELLP syndrome: Therapeutic plasma exchange

ERKURT M. A., Berber İ., Berktas H. B., KUKU İ., KAYA E., Koroglu M., et al.

TRANSFUSION AND APHERESIS SCIENCE , cilt.52, sa.2, ss.194-198, 2015 (SCI-Expanded)

74. Can BuCyE conditioning regimen be an alternative treatment to BEAM at autologous transplantation in malignant lymphoma patients?: a single center experience

BERBER İ., ERKURT M. A., NIZAM I., KOROGLU M., KAYA E., KUKU İ., et al.

INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE , cilt.8, sa.9, ss.16308-16314, 2015 (SCI-Expanded)

75. Carcinoma Causing Thrombotic Thrombocytopenic Purpura and Myelonecrosis A Very Rare Event

NİZAM İ., ERKURT M. A., BERBER İ., KÖROĞLU M., KAYA E., KUKU İ., et al.

American Journal of Medical Case Reports , cilt.3, sa.11, ss.372-373, 2015 (Hakemli Dergi)

76. Myocardial Infarction in a Splenectomized Patient with Immune Trombocytopenia

NİZAM İ., ERKURT M. A., BERBER İ., KAYA E., KUKU İ., KÖROĞLU M.

American Journal of Medical Case Reports , cilt.3, sa.9, ss.301-303, 2015 (Hakemli Dergi)

77. Cytotoxic effect of benzimidazole metal complex compounds on lung cancer cells A549

APOHAN E., YEŞİLADA Ö., Yılmaz Ö., Serindağ A., YILMAZ Ü., KÜÇÜKBAY H., et al.

Journal of Biotechnology and Biomaterials , cilt.5, sa.2, ss.73, 2015 (Hakemli Dergi)

78. Diclofenac Related Spontaneous Extensive Ecchymosis and Hematoma despite Normal Coagulation Parameters

BERBER İ., ERKURT M. A., NİZAM İ., KUKU İ., KAYA E., ünlü s., et al.

American Journal of Medical Case Reports , cilt.3, sa.3, ss.82-84, 2015 (Hakemli Dergi)

79. Thrombotic thrombocytopenic purpura presenting with pathologic fracture: a case report

Berber İ., ERKURT M. A., KUKU İ., KAYA E., Unlu S., ERTEM K., et al.

TRANSFUSION AND APHERESIS SCIENCE , cilt.51, sa.1, ss.73-76, 2014 (SCI-Expanded)

80. BK Virus in Allogeneic and Autologous Bone Marrow Transplantation

BERBER İ., ERKURT M. A., KUKU İ., KAYA E.

American Journal of Medical Sciences And Medicine , 2014 (Hakemli Dergi)

81. As a Rare Disease Bernard Soulier Syndrome in Differential Diagnosis of Immune Thrombocytopenic Purpura A Case Report

BERBER İ., ERKURT M. A., YARARBAŞ K., KÖROĞLU M., NİZAM İ., BERKTAŞ H. B., et al.

American Journal of Medical Case Reports , cilt.2, sa.5, ss.102-106, 2014 (Hakemli Dergi)

82. Atypical Presentation of Plasmacytoma

BERBER İ., ERKURT M. A., YARARBAŞ K., KÖROĞLU M., NİZAM İ., BERKTAŞ H. B., et al.

American Journal of Medical Case Reports , cilt.2, sa.4, ss.82-83, 2014 (Hakemli Dergi)

83. Acute Myeloid Leukemia Significance of the Skin Test

BERBER İ., ERKURT M. A., YARARBAŞ K., KÖROĞLU M., NİZAM İ., BERKTAŞ H. B., et al.

American Journal of Medical Case Reports , cilt.2, sa.3, ss.55-56, 2014 (Hakemli Dergi)

84. Aggressive Progression of Mantle Cell Lymphoma ACase Report

NİZAM İ., ERKURT M. A., BERBER İ., KAYA E., KUKU İ., KÖROĞLU M.

American Journal of Medical Case Reports , cilt.2, sa.1, ss.30-31, 2014 (Hakemli Dergi)

85. Hermansky-Pudlak Syndrome: A Case Report

BERBER İ., ERKURT M. A., KUKU I., Kaya E., KOROGLU M., NIZAM I., et al.

CASE REPORTS IN HEMATOLOGY , cilt.2014, 2014 (ESCI)

86. Haploidentical Transplantation Experience in Turgut Ozal MedicalCenter Case Report and a Review of Literature

BERBER İ., ERKURT M. A., KAYA E., KÖROĞLU M., NİZAM İ., BENTLİ R., et al.

Journal of Turgut Ozal Medicine , cilt.21, sa.1, ss.55-58, 2014 (Hakemli Dergi)

87. Decitabine Induced Localized Maculopapular Eruption

BERBER İ., ERKURT M. A., KÖROĞLU M., BENTLİ R., NİZAM İ., KAYA E., et al.

British Journal of Medicine and Medical Research , cilt.4, sa.4, ss.1002-1007, 2014 (Hakemli Dergi)

88. Evaluation of ferric and ferrous iron therapies in women with iron deficiency anaemia.

BERBER I., DIRI H., ERKURT M. A., AYDOGDU I., Kaya E., KUKU I.

Advances in hematology , cilt.2014, ss.297057, 2014 (Scopus) Sürdürülebilir Kalkınma

89. An Unexpected Complication of Bone Marrow Aspiration and Trephine Biopsy: Arteriovenous Fistula

Berber İ., ERKURT M. A., KUKU İ., KAYA E., KUTLU R., Koroglu M., et al.

MEDICAL PRINCIPLES AND PRACTICE , cilt.23, sa.4, ss.380-383, 2014 (SCI-Expanded)

90. BK Virus in Allogeneic and Autologous Bone Marrow Transplantation Review Article

BERBER İ., ERKURT M. A., YETKİN F., KUKU İ., KAYA E., bodakcı e., et al.

American Journal of Medical Sciences and Medicine , cilt.2, sa.5, ss.85-88, 2014 (Hakemli Dergi)

91. Donor Selection in Allogeneic Stem Cell Transplantation

ERKURT M. A., BERBER İ., KUKU İ., KAYA E., NİZAM İ.

American Journal of Clinical Medicine Research , cilt.2, sa.1, ss.32-35, 2014 (Hakemli Dergi)

92. Etiologic Evaluation of 1012 Patients Admitted with Thrombocytopenia

ERKURT M. A., BERBER İ., NİZAM İ., KAYA E., KÖROĞLU M., KUKU İ., et al.

British Journal of Medicine and Medical Research , cilt.4, sa.1, ss.104-113, 2014 (Hakemli Dergi)

93. Primarily unknown origin adenocarcinoma metastasis in bone marrow presenting with thrombotic thrombocytopenic purpura: A case report

Koroglu M., ERKURT M. A., Berber İ., KUKU İ., KAYA E., Ozkahraman A., et al.

TRANSFUSION AND APHERESIS SCIENCE , cilt.49, sa.2, ss.341-344, 2013 (SCI-Expanded)

94. Clinicopathological Characteristics of Pernicious Anemia A Study of 300 Patients in Turkey

BENTLİ R., BERBER İ., ERKURT M. A., AYDOĞDU İ., GÜNDÜZ E., NİZAM İ., et al.

British Journal of Medicine and Medical Research , cilt.4, sa.3, 2013 (Hakemli Dergi)

95. Evans Seyndrome

BERBER İ., ERKURT M. A., KÖROĞLU M., BENTLİ R., KAYA E., KUKU İ.

Journal Of Turgut Ozal Medical Center , cilt.20, sa.3, ss.289-290, 2013 (Hakemli Dergi)

96. Extranasal NK Cell Lymphoma with Extensive Skin Involvement A Case Report

ERKURT M. A., BERBER İ., KARADAĞ N., BENTLİ R., KAYA E., KÖROĞLU M., et al.

Journal Of Turgut Ozal Medical Center , cilt.20, sa.3, ss.276-278, 2013 (Hakemli Dergi)

97. Familial Chronic Lymphocytic Leukemia Patients in Eastern Anatolia Region

BERBER İ., ERKURT M. A., KÖROĞLU M., BENTLİ R., KAYA E., KUKU İ.

Journal Of Turgut Ozal Medical Center , cilt.20, sa.3, ss.287-288, 2013 (Hakemli Dergi)

98. Therapeutic plasma-exchange in hematologic disease: Results from a single center in Eastern Anatolia

ERKURT M. A., Kuku L., KAYA E., Ozgen U., Berber İ., Koroglu M., et al.

TRANSFUSION AND APHERESIS SCIENCE , cilt.48, sa.3, ss.335-339, 2013 (SCI-Expanded)

99. Therapeutic plasma exchange in patients with neurological diseases: Multicenter retrospective analysis

KAYA E., KEKLİK M., ŞENCAN M., Yilmaz M., Keskin A., KİKİ İ., et al.

TRANSFUSION AND APHERESIS SCIENCE , cilt.48, sa.3, ss.349-352, 2013 (SCI-Expanded) Sürdürülebilir Kalkınma

100. Effect of endogen-exogenous melatonin and erythropoietin on dinitrobenzene sulfonic acidinduced colitis

Tasdemir S., PARLAKPINAR H., VARDI N., KAYA E., Acet A.

FUNDAMENTAL & CLINICAL PHARMACOLOGY , cilt.27, sa.3, ss.299-307, 2013 (SCI-Expanded)

101. Therapeutic plasma exchange in patients with thrombotic thrombocytopenic purpura: A retrospective multicenter study

KORKMAZ S., KEKLİK M., Sivgin S., Yildirim R., TOMBAK A., Kaya M. E., et al.

TRANSFUSION AND APHERESIS SCIENCE , cilt.48, sa.3, ss.353-358, 2013 (SCI-Expanded)

102. Doğu Anadolu Bölgesindeki Ailesel Kronik Lenfositik Lösemili Hastalarımız

BERBER İ., ERKURT M. A., KÖROĞLU M., BENTLİ R., KAYA E., KUKU İ.

İnönü Üniversitesi Tıp Fakültesi Dergisi , cilt.20, sa.3, ss.287-288, 2013 (Hakemli Dergi)

103. Burkitt s lymphoma presenting with rapidly and multi organ involvement A case presentation

BERBER İ., ERKURT M. A., KÖROĞLU M., KUKU İ., KAYA E., BENTLİ R.

Case Reports in Clinical Medicine , cilt.2, sa.04, ss.242-245, 2013 (Hakemli Dergi)

104. Double Hit Lymphoma Presenting with Aggressive Progression A CaseReport

KAYA E., ERKURT M. A., BERBER İ., KÖROĞLU M., KUKU İ.

Journal Of Turgut Ozal Medical Center , cilt.20, sa.1, ss.74-76, 2013 (Hakemli Dergi)

105. After allogenic bone marrow transplantation agent of hemorrhagic cystitis BK virus

BERBER İ., KÖROĞLU M., ERKURT M. A., OĞUZ F., ALTINTAŞ R., KAYA E., et al.

Case Reports in Clinical Medicine , cilt.2, sa.5, ss.298-301, 2013 (Hakemli Dergi)

106. A Rare Case of Chronic Myeloid Leukemia At a Patient with Achondroplasia

NİZAM İ., ERKURT M. A., BERBER İ., KAYA E., KUKU İ.

American Journal of Medical Case Reports , 2013 (Hakemli Dergi)

107. A Rare Disease in Adult Langerhans Cell Histiocytosis

BERBER İ., ERKURT M. A., KUKU İ., KÖROĞLU M., KAYA E., ÜNLÜ S.

World Journal of Oncology , cilt.4, sa.3, ss.165-168, 2013 (ESCI)

108. Evans Syndrome

BERBER İ., ERKURT M. A., KÖROĞLU M., BENTLİ R., KAYA E., KUKU İ.

İnönü Üniversitesi Tıp Fakültesi Dergisi , cilt.20, sa.3, ss.289-290, 2013 (Hakemli Dergi)

109. Thrombocytopenia in Adults Review Article

ERKURT M. A., KAYA E., BERBER İ., KÖROĞLU M., KUKU İ.

Journal of Hematology , cilt.1, ss.44-53, 2012 (ESCI)

110. Intracranial involvement in a patient with Hodgkin's lymphoma

CÖMERT M., BASSULLU N., KAYA E., KOCAK A.

SINGAPORE MEDICAL JOURNAL , cilt.52, sa.9, 2011 (SCI-Expanded)

111. Interpedicular Approach in Percutaneous Sacroplasty for Treatment of Sacral Vertebral Body Pathologic Fractures

FIRAT A. K., Gumus B., KAYA E., KUKU İ., HARMA A.

CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY , cilt.34, 2011 (SCI-Expanded)

112. Addition of thalidomide to oral melphalan/prednisone in patients with multiple myeloma not eligible for transplantation: results of a randomized trial from the Turkish Myeloma Study Group

Beksac M., Haznedar R., Firatli-Tuglular T., Ozdogu H., Aydogdu I., Konuk N., et al.

EUROPEAN JOURNAL OF HAEMATOLOGY , cilt.86, sa.1, ss.16-22, 2011 (SCI-Expanded)

113. The levels of nitric oxide in megaloblastic anemia

ERKURT M. A., Aydogdu I., BAYRAKTAR N., KUKU İ., KAYA E.

TURKISH JOURNAL OF HEMATOLOGY , cilt.26, sa.4, ss.197-200, 2009 (SCI-Expanded)

114. A multicentric, hyaline vascular variant of Castleman's disease associated with B cell lymphoma: a case report.

ERKURT M. A., AYDOGDU I., KUKU I., Kaya E., MIZRAK B., BASARAN Y.

Cases journal , cilt.2, ss.8183, 2009 (Hakemli Dergi)

115. Nodular melanoma presenting with rapid progression and widespread metastases: a case report.

ERKURT M. A., AYDOGDU I., KUKU I., Kaya E., BASARAN Y.

Journal of medical case reports , cilt.3, ss.50, 2009 (Scopus)

116. Clinicopathologic Characteristics and Therapeutic Outcomes of Primary Gastrointestinal Non-Hodgkin's Lymphomas: 10 Years of Experience from a Single Center in Eastern Anatolia

ERKURT M. A., Aydogdu I., KUKU İ., KAYA E., Basaran Y.

MEDICAL PRINCIPLES AND PRACTICE , cilt.18, sa.5, ss.399-406, 2009 (SCI-Expanded)

117. Platelet counts in adults with iron deficiency anemia

KUKU İ., KAYA E., YOLOĞLU S., Gokdeniz R., BAYDIN A.

PLATELETS , cilt.20, sa.6, ss.401-405, 2009 (SCI-Expanded) Sürdürülebilir Kalkınma

118. Kanser kemoterapisi ve böbrek

ERKURT M. A., KUKU İ., KAYA E., AYDOĞDU İ.

TURGUT ÖZAL TIP DERGİSİ , cilt.16, sa.1, ss.63-68, 2009 (Hakemli Dergi) Sürdürülebilir Kalkınma

119. Anticancer drug induced glomerular dysfunction

ERKURT M. A., AYDOĞDU İ., KUKU İ., KAYA E., ÖZHAN O.

World Journal of Medical Sciences , cilt.3, sa.1, ss.5-9, 2008 (Hakemli Dergi)

120. Effects of cyanocobalamin on immunity in patients with pernicious anemia

ERKURT M. A., AYDOGDU I., Dikilitas M., KUKU İ., KAYA E., BAYRAKTAR N., et al.

MEDICAL PRINCIPLES AND PRACTICE , cilt.17, sa.2, ss.131-135, 2008 (SCI-Expanded)

121. Therapeutic plasma exchange for the treatment of thrombotic thrombocytopenic purpura: A retrospective multicenter study

Altuntas F., Aydogdu I., Kabukcu S., KOÇYİĞİT İ., Cikim K., Sari I., et al.

TRANSFUSION AND APHERESIS SCIENCE , cilt.36, sa.1, ss.57-67, 2007 (SCI-Expanded)

122. Two Uncommon Manifestations in Bardet Biedl Syndrome

Serbest S., Şahin İ., Taşkapan H., Lezzan K., Kaya E.

Journal of Turgut Ozal Medical Center , cilt.14, 2007 (Hakemli Dergi)

123. Retrospective analysis of patients with idiopathic thrombocytopenic purpura from eastern Anatolia

KAYA E., Erkurt M. A., Aydogdu I., Kuku I., Ozhan O., Oner R. I., et al.

MEDICAL PRINCIPLES AND PRACTICE , cilt.16, sa.2, ss.100-106, 2007 (SCI-Expanded) Sürdürülebilir Kalkınma

124. Transfusion-associated graft-versus-host disease in patients with and without immunodeficiency: Report of six cases

Aydogdu I., KAYA E., Karadag N., Erkurt M. A., Kuku I., Ozhan O., et al.

TRANSFUSION MEDICINE AND HEMOTHERAPY , cilt.34, sa.1, ss.79-82, 2007 (SCI-Expanded)

125. Rheumatic diseases and chronic myelogenous leukemia, presentation of four cases and review of the literature

Senel S., KAYA E., Aydogdu I., Erkurt M., Kuku I.

RHEUMATOLOGY INTERNATIONAL , cilt.26, sa.9, ss.857-861, 2006 (SCI-Expanded)

126. Reversible bone marrow necrosis in a patient due to overdosage of diclofenac sodium

Aydogdu I., Erkurt M., Ozhan O., Kaya E., Kuku I., Yitmen E., et al.

AMERICAN JOURNAL OF HEMATOLOGY , cilt.81, sa.4, ss.298, 2006 (SCI-Expanded)

127. Malatya İl Merkezinde Farklı Sosyoekonomik Düzeydeki İki İlköğretim Okulunda Demir Eksikliği Anemisi Yaygınlığı

KAYA M., PEHLİVAN E., AYDOĞDU İ., GENÇ M. F., GÜNEŞ G., KAYA E., et al.

TURGUT ÖZAL TIP MERKEZİ DERGİDİ , cilt.13, sa.4, ss.237-242, 2006 (Hakemli Dergi) Sürdürülebilir Kalkınma

128. Elevated nucleated red blood cell count: A population-based study

USTUN Y., ENGIN-USTUN Y., Kaya E., MEYDANLI M., KULAK N.

JOURNAL OF REPRODUCTIVE MEDICINE , cilt.51, sa.1, ss.36-40, 2006 (SCI-Expanded)

129. Clinical experience with three combination regimens for the treatment of high-risk febrile neutropenia

Serefhanoglu K., Ersoy Y., Serefhanoglu S., Aydogdu I., Kuku I., Kaya E.

ANNALS ACADEMY OF MEDICINE SINGAPORE , cilt.35, sa.1, ss.11-16, 2006 (SCI-Expanded)

130. Decreased Tc-99m MDP uptake in myelonecrosis

Kekilli E., Yagmur C., KAYA E., Kuku I., Ertem K., Aydogdu I.

CLINICAL NUCLEAR MEDICINE , cilt.31, sa.1, ss.33, 2006 (SCI-Expanded)

131. Oxidant/antioxidant parameters and their relationship with chemotherapy in Hodgkin's lymphoma

Kaya E., Keskin L., Aydogdu I., Kuku I., Bayraktar N., Erkut M.

JOURNAL OF INTERNATIONAL MEDICAL RESEARCH , cilt.33, sa.6, ss.687-692, 2005 (SCI-Expanded)

132. Serum proinflammatory mediators at different periods of therapy in patients with multiple myeloma

Kuku I., Bayraktar M., KAYA E., Erkurt M., Bayraktar N., Cikim K., et al.

MEDIATORS OF INFLAMMATION , sa.3, ss.171-174, 2005 (SCI-Expanded)

133. Bone relapse in a patient with acute lymphoblastic leukaemia.

AYDOGDU I., Erkurt A., Kaya E., KUKU I.

British journal of haematology , cilt.129, ss.163, 2005 (SCI-Expanded)

134. Rhino-orbito-cerebral mucormycosis in transfusion-associated graft-versus-host disease: Case report

Bayindir Y., Aydogdu I., Bayindir T., Kaya E., Kuzucu C., Alkan A., et al.

TRANSFUSION MEDICINE AND HEMOTHERAPY , cilt.32, sa.5, ss.252-254, 2005 (SCI-Expanded) Sürdürülebilir Kalkınma

135. Oxidant/antioxidant parameters and their relationship with medical treatment in multiple myeloma

Kuku I., Aydogdu I., Bayraktar N., KAYA E., Akyol O., Erkurt M.

CELL BIOCHEMISTRY AND FUNCTION , cilt.23, sa.1, ss.47-50, 2005 (SCI-Expanded)

136. Malatya ve Çevresi ABO ve Rh Kan Grubu Dağılımı

KUKU İ., KAYA E., ERKURT M. A., DİKİLİTAŞ M., YILDIZ R., ORHAN M., et al.

Turgut Özal Tıp Merkezi Dergisi , cilt.11, sa.4, ss.213-215, 2004 (Hakemli Dergi) Sürdürülebilir Kalkınma

137. Blastic natural killer cell leukaemia with skin involvement: a case report

KAYA E., Ozcan H., Kuku I., Dikilitas M., Sevinc A., Aydogdu I.

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY , cilt.18, sa.1, ss.86-88, 2004 (SCI-Expanded)

138. Hiperlökositozlu lösemi hastalarımızda terapötik ve proflaktik lökoferez Deneyimlerimiz

KUKU İ., KAYA E., ERKURT M. A., UZER E., ÖZGÜL M., DİKİLİTAŞ M., et al.

Turgut Özal Tıp Merkezi Dergisi , cilt.11, sa.4, ss.243-246, 2004 (Hakemli Dergi)

139. A case of rhabdomyolysis accompanying acute renal failure secondary to weight lifting

BAYSAL O., Taskapan H., Taskapan C., Kaya E., Sahin I., KIRIMLIOGLU H., et al.

CLINICAL NEPHROLOGY , cilt.60, sa.4, ss.296-297, 2003 (SCI-Expanded)

140. Transient severe thrombocytopenia in a patient on CAPD after intravenous iron administration

Taskapan H., Bahceci F., Taskapan C., Sahin I., Kaya E., Aydogdu I.

PERITONEAL DIALYSIS INTERNATIONAL , cilt.23, sa.4, ss.408-409, 2003 (SCI-Expanded)

141. Bilateral hearing loss during vincristine therapy: A case report

Kalcioglu M., Kuku I., KAYA E., Oncel S., Aydogdu I.

JOURNAL OF CHEMOTHERAPY , cilt.15, sa.3, ss.290-292, 2003 (SCI-Expanded) Sürdürülebilir Kalkınma

142. Isolated thrombocytopenia: the presenting finding of typhoid fever

Serefhanoglu K., KAYA E., Sevinc A., Aydogdu I., Kuku I., Ersoy Y.

CLINICAL AND LABORATORY HAEMATOLOGY , cilt.25, sa.1, ss.63-65, 2003 (SCI-Expanded) Sürdürülebilir Kalkınma

143. Development of large genital ulcer due to hydroxyurea treatment in a patient with chronic myeloid leukemia and Behcet's disease

Karincaoglu Y., KAYA E., Esrefoglu M., Aydogdu I.

LEUKEMIA & LYMPHOMA , cilt.44, sa.6, ss.1063-1065, 2003 (SCI-Expanded)

144. Does cardiopulmonary bypass alter plasma level of tumor markers? CA 125 and carcinoembryonic antigen

Battaloglu B., KAYA E., Erdil N., Nisanoglu V., Kosar F., Ozgur B., et al.

THORACIC AND CARDIOVASCULAR SURGEON , cilt.50, sa.4, ss.201-203, 2002 (SCI-Expanded)

145. Gemcitabine-induced erysipeloid skin lesions in a patient with malignant mesothelioma

Kuku I., KAYA E., Sevinc A., Aydogdu I.

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY , cilt.16, sa.3, ss.271-272, 2002 (SCI-Expanded) Sürdürülebilir Kalkınma

146. Bilateral transient hearing loss associated with vincristine therapy: Case report

Aydogdu I., Ozturan O., Kuku I., KAYA E., Sevinc A., Yildiz R.

JOURNAL OF CHEMOTHERAPY , cilt.12, sa.6, ss.530-532, 2000 (SCI-Expanded)

147. Vipoma Sendromu

ALBAYRAK A., KONUKSAL F., BERBEROĞLU M., KILIÇ G., KAYA E., AKDOĞAN M. F.

Türkiye Klinikleri Gastroenterohepatoloji Dergisi , cilt.5, sa.4, ss.245-248, 1994 (Hakemli Dergi)

148. Yoğun bakım hastalarında dissemine intravasküler koagulasyon

İDİKUT T., ALBAYRAK A., KONUKSAL F., AKDOĞAN F., SEMERCİ F., KAYA E.

HAYDARPAŞA NUMUNE EĞİTİM VE ARAŞTIRMA HASTANESİ TIP DERGİSİ , cilt.32, ss.159-161, 1992 (Hakemli Dergi)

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 69

1. REFRAKTER KRONİK İTP’ DE DANAZOL TEDAVİSİ

ARSLAN S., KAYA E., KUKU İ., ERKURT M. A., BERBER İ., KAYA A.

50. Ulusal Hematoloji Kongresi - 2024, 29 Ekim - 02 Kasım 2024, (Özet Bildiri)

2. İnönü University Turgut Özal Medical Center Red Crescent Pool Platelet Experience

HİDAYET E., ERKURT M. A., KUKU İ., KAYA E., BERBER İ., SARICI A., et al.

WORLD APHERESIS ASSOCIATION THE EUROPEAN SOCIETY FOR HEMAPHERESIS THE TURKISH SOCIETY OF HEMATOLOGICAL RARE DISEASES HYBRID JOINT CONGRESS, İstanbul, Türkiye, 14 - 17 Eylül 2022, (Tam Metin Bildiri)

3. APLASTİK ANEMİ İLE BİRLİKTELİĞİ OLAN VE OLMAYAN PNHHASTALARINDA ALLOJENEİK KÖK HÜCRE NAKLİ DENEYİMİ

YILMAZ A. F., SOYER N., CENGİZ SEVAL G., CİVRİZ BOZDAĞ S., TOPÇUOĞLU P., ÜNAL A., et al.

46. Ulusal Hematoloji Kongresi, Türkiye, 28 - 31 Ekim 2020, ss.86, (Tam Metin Bildiri)

4. Ibrutinib As a Promising Treatment for Pulmonary Complications Due to Refractory Chronic Graft Versus Host Disease

İLHAN O., Seval G. C., Uzay A., KAYA E., Ozturk Z. N., Deveci B., et al.

Transplantation and Cellular Therapy (TCT) Meetings of ASTCT and CIBMTR, Florida, Amerika Birleşik Devletleri, 19 - 23 Şubat 2020, cilt.26, (Özet Bildiri)

5. Evaluation of Patients with PNH Treated By Eculizumab: Real World Data from Turkey

KEKLİK KARADAĞ F., YENEREL M. N., YILMAZ M., ÜSKÜDAR TEKE H., ÖZKOCAMAN V., TUĞLULAR A. T., et al.

101.RED CELLS AND ERYTHROPOIESIS, STRUCTURE AND FUNCTION, METABOLISM, AND SURVIVAL, EXCLUDING IRON NOVEMBER 13, 2019, 13 - 17 Kasım 2019, cilt.134, ss.4805, (Özet Bildiri)

6. TANI ANINDA BÖBREK YETMEZLİĞİ OLAN MULTİPL MYELOM HASTALARININ TEDAVİ SONRASI BÖBREK FONKSİYONLARININ DEĞİŞİMİ

SARICI A., KAYA E., ERKURT M. A., TANRIVERDİ L. H., BERBER İ., BAHÇECİOĞLU Ö. F., et al.

45. Ulusal Hematoloji Kongresi, Antalya, Türkiye, 30 Ekim - 02 Kasım 2019, ss.219, (Özet Bildiri)

7. Efficacy and Safety of Ibrutinib Use in Patients with Chronic Lymphocytic Leukemia in Real World Experiences: Results of a Prospective Multicenter Study

Tombak A., Tanrikulu F. P., Durusoy S. S., GÜRKAN E., KAYA E., ÜMİT E. G., et al.

61st Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), Florida, Amerika Birleşik Devletleri, 7 - 10 Aralık 2019, cilt.134, (Özet Bildiri)

8. TÜRKİYE’DE PAROKSİSMAL NOKTÜRNAL HEMOGLOBİNÜRİDEN ŞÜPHELENİLEN HASTALARIN ÇOKMERKEZLİ TANISAL TARAMA ÇALIŞMASI

İLHAN O., ÖZDEMİR Z. N., ÖZET G., FALAY M., YENEREL M. N., TUĞLULAR A. T., et al.

45. Ulusal Hematoloji Kongresi, Antalya, Türkiye, 30 Ekim - 02 Kasım 2019, ss.131-132, (Tam Metin Bildiri)

9. YAŞAM SÜRESİNİ VE KALİTESİNİ ETKİLEYEN DİRENÇLİ KGVHH TEDAVİSİNDE YENİ BİR YAKLAŞIMBTK İNHİBİTÖRÜ:GERÇEK YAŞAM VERİSİ

İLHAN O., Seval G. C., UZAY A., KAYA E., DEVECİ B., YAVAŞOĞLU İ., et al.

45. Ulusal Hematoloji Kongresi, Türkiye, 30 Ekim - 02 Kasım 2019, (Tam Metin Bildiri)

10. GRAFT VERSUS HOST HASTALIĞINDA İBRUTİNİBKULLANIMI: TEK MERKEZ DENEYİMİ

ÖZKAN S. G., KAYA E., ERKURT M. A., SARICI A., BERBER İ., KUKU İ.

45. ULUSAL HEMATOLOJİ KONGRESİ, Antalya, Türkiye, 30 Ekim - 02 Kasım 2019, (Tam Metin Bildiri)

11. Non-Hodgkin Lenfoma Hastalarının Klinik ve Patolojik Özellikleri: Tek Merkez Deneyimi.

YILDIRIM DOĞAN N., ERKURT M. A., DOĞAN A., EKİNCİ Ö., KUKU İ., KAYA E.

44. Ulusal Hematoloji Kongresi., 31 Ekim - 03 Kasım 2018, (Özet Bildiri)

12. GERÇEK YAŞAMDA KRONİK LENFOSİTİK LÖSEMİLİHASTALARDA İBRUTİNİB KULLANIMININ ETKİNLİĞİVE GÜVENİLİRLİĞİ: RETROSPEKTİF ÇOK MERKEZLİÇALIŞMANIN SONUÇLARI

TOMBAK A., TANRIKULU PEPEDİL F., DURUSOY S. S., GÜRKAN E., KAYA E., ÜMİT E. G., et al.

44. ULUSAL hEMATOLOJİ kONGRESİ, Antalya, Türkiye, 31 Ekim - 03 Kasım 2018, (Özet Bildiri)

13. Relation of basal vitamin D and parathyroid hormone levels to CD34 cell counts in multiple myeloma and lymphoma patients with stem cell mobilization

KAYA A., KAYA E., ERKURT M. A., KUKU İ.

9th International Eurasian Hematology Oncology Congress, İstanbul, Türkiye, 17 - 20 Ekim 2018, cilt.73, sa.1, ss.34-70, (Tam Metin Bildiri)

14. Clinical and pathological characteristics of non-Hodgkin lymphoma patients in eastern Turkey: a single-center study.

YILDIRIM DOĞAN N., ERKURT M. A., DOĞAN A., EKİNCİ Ö., KUKU İ., KAYA E.

IXth International Eurasian Hematology Oncology Congress., İstanbul, Türkiye, 17 - 20 Ekim 2018, cilt.73, (Özet Bildiri)

15. Relation of Basal Vitamin D and Parathyroid Hormone Levels to CD34+ Cell Counts in Multiple Myeloma and Lymphoma Patients with Stem Cell Mobilization

KAYA A., KAYA E., ERKURT M. A., KUKU İ.

IX. International Eurasian Hematology-Oncology Congress, İstanbul, Türkiye, 17 - 20 Ekim 2018, cilt.73, (Tam Metin Bildiri)

16. Thrombocytapheresis decreases systolic blood pressure and increases sympatho-vagal balance

ERKURT M. A., KAYA E., KUKU İ., YILDIZ S.

9th International Eurasian Hematology Oncology Congress, İstanbul, Türkiye, 17 - 20 Ekim 2018, cilt.73, (Tam Metin Bildiri)

17. Philadelphia Kromozomu Negatif Hastalarda JAK2 V617F Gen Mutasyonunun Değerlendirilmesi

GÜLBAY G., YEŞİLADA E., ERKURT M. A., GÖZÜKARA BAĞ H. G., KAYA E., KUKU İ.

V.Uluslararası Katılımlı Deneysel Hematoloji Kongresi, Malatya, Türkiye, 27 - 29 Nisan 2018, (Özet Bildiri)

18. Akut Myeloid Lösemili Olgularımızda T(15 17) PML-RARA, T(8 21) RUNX1-RUNX1T1, inv 16 CBFB-MYH11A ve t(9 22) BCR-ABL1 Pozitifliğinin Araştırılması

GÜLBAY G., YEŞİLADA E., ERKURT M. A., GÖZÜKARA BAĞ H. G., KAYA E., KUKU İ.

V.Uluslararası Katılımlı Deneysel Hematoloji Kongresi, Malatya, Türkiye, 27 - 29 Nisan 2018, (Özet Bildiri)

19. Türk Hastalarda Jak2 V617f Gen Mutasyonunun Değerlendirilmesi: Doğu Anadolu’xxdan Tek Merkez Deneyimi

GÜLBAY G., YEŞİLADA E., ERKURT M. A., GÖZÜKARA BAĞ H. G., KUKU İ., KAYA E.

I. Hematolojik Nadir Hastalıklar Kongresi, Girne, Kıbrıs (Kktc), 8 - 10 Şubat 2018, ss.40, (Özet Bildiri)

20. myokard infarktüsü ile prezente olan izole trombositozlu kronik myeloid lösemi: olgu sunumu

CIRIK S., ÖZKAN M., KAYA E., KUKU İ., ERKURT M. A.

43.Ulusal Hematoloji Kongresi, Türkiye, 1 - 04 Kasım 2017, (Özet Bildiri)

21. kronik myeloproliferatif neoplazili hastalarda ruksolitinib etkinlik ve güvenliği: çok merkezli ve geriye dönük çalışma

SOYER N., TURGUT M., HAZNEDAROĞLU İ. C., YILMAZ A. F., AYDOĞDU İ., PİR A., et al.

43.ulusal hematoloji kongresi, Türkiye, 1 - 04 Kasım 2017, (Özet Bildiri)

22. KRONİK MYELOPROLİFERATİF NEOPLAZİLİ HASTALARDA RUKSOLİTİNİB ETKİNLİK VE GÜVENLİĞİ: ÇOK MERKEZLİ VE GERİYE DÖNÜK ÇALIŞMA.

SOYER N., TURGUT M., HAZNEDAROĞLU İ. C., YILMAZ A. F., AYDOĞDU İ., PİR A., et al.

43. Ulusal Hematoloji Kongresi, Antalya, Türkiye, 1 - 04 Kasım 2017, (Özet Bildiri)

23. MİYOKARD İNFARKTÜSÜ İLE PREZENTE OLAN İZOLETROMBOSİTOZLU KRONİK MYELOİD LÖSEMİ:OLGU SUNUMU

CIRIK S., ÖZKAN M., KAYA E., KUKU İ., ERKURT M. A.

43. Ulusal Hematoloji Kongresi, Türkiye, 1 - 04 Kasım 2017, (Tam Metin Bildiri)

24. KRONİK MYELOPROLİFERATİF NEOPLAZİLİ HASTALARDARUKSOLİTİNİB ETKİNLİK VE GÜVENLİĞİ: ÇOK MERKEZLİ VEGERİYE DÖNÜK ÇALIŞMA

SOYER N., TURGUT M., HAZNEDAROĞLU İ. C., YILMAZ F., AYDOĞDU İ., PİR A., et al.

43. Ulusal Hematoloji Kongresi, Türkiye, 1 - 04 Kasım 2017, (Tam Metin Bildiri)

25. MYELOM SEYRİNDE ASİT OLUŞUMU

ÖZKAN M., KUŞCU A., KUKU İ., KAYA E., ERKURT M. A.

43. Ulusal Hematoloji Kongresi, Türkiye, 1 - 04 Kasım 2017, (Tam Metin Bildiri)

26. BORTEZOMİB İLİŞKİLİ İŞİTME KAYBI

ÖZKAN M., ÖZEN İ. N., KUKU İ., KAYA E., ERKURT M. A.

43. Ulusal Hematoloji Kongresi, Türkiye, 1 - 04 Kasım 2017, (Tam Metin Bildiri)

27. TÜRKİYE’DE PAROKSİSMAL NOKTÜRNALHEMOGLOBİNÜRİDEN ŞÜPHELENİLEN HASTALARINSIKLIĞININ SAPTANMASINA YÖNELİK ÇALIŞMA

İLHAN O., ÖZET G., FALAY M., YENEREL M. N., TURGUT M., ÜNAL A., et al.

43. Ulusal Hematoloji Kongresi, Türkiye, 1 - 05 Kasım 2017, (Tam Metin Bildiri)

28. Mean corpuscular volüme can be early predictor for molecular response in chronic phase chronic myeloid leukemia patients

ÖZKAN M., KAYA E., CIRIK S., KUKU İ., ERKURT M. A.

VIII. International Eurasian Hematology-Oncology Congress, İstanbul, Türkiye, 18 - 21 Ekim 2017, cilt.61, sa.1, ss.52, (Özet Bildiri)

29. MEAN CORPUSCULAR VOLUME CAN BE AN EARLY PREDICTOR FOR MOLECULAR RESPONSE IN CHRONIC PHASE CHRONIC MYELOID LEUKEMIA PATIENTS

Ozkan M. C., KAYA E., Cirik S., Kuku I., Erkurt M.

8th International Eurasian Hematology Oncology Congress (EHOC), İstanbul, Türkiye, 18 - 21 Ekim 2017, cilt.61, (Özet Bildiri)

30. Myeloid Sarcoma of the Tongue with Myelodysplastic Syndrome: A Case Report

CIRIK S., ÖZKAN M., KUKU İ., KAYA E., ERKURT M. A.

4th Aegean Hematology Oncology Congress, 21 - 24 Eylül 2017, (Özet Bildiri)

31. Bortezomib Associated Hearing Loss

ÖZKAN M., KAYA E., ERKURT M. A., KUKU İ.

4Th Aegean Hematology Oncology Congress, 21 - 24 Eylül 2017, (Özet Bildiri)

32. Efficiacy and safety of ruxolitinib in Turkish patients with chronic myeloprolipherative neoplasms:A multicenter and retropective analysis

SOYER N., KAYA E.

4th AEGAN HEMATOLOGY ONCOLOGY SYMPOSIUM, Rodos, Yunanistan, 21 - 24 Eylül 2017, ss.94-95, (Tam Metin Bildiri)

33. Efficacy and safety of Ruxolitinib in Turkish Patients with chronic myeloproliferatif neoplasms:A multicenter and retrospective analysis

SOYER N., TURGUT M., HAZNEDAROĞLU İ. C., yılmaz f., AYDOĞDU İ., PİR A., et al.

AHOS, 21 - 24 Eylül 2017, (Özet Bildiri)

34. Bortezomib associated hearing loss

ÖZKAN M. C., ÖZEN İ. N., KUKU İ., KAYA E., ERKURT M. A.

4th Aegean Hematology Oncology Symposium, 21 - 24 Eylül 2017, (Tam Metin Bildiri)

35. A Multicenter Experience of Thrombotic Microangiopathies in Turkey: The Turkish Hematology Research and Education Group (ThREG)-TMA01 Study

Tekgunduz E., YILMAZ M., ERKURT M. A., KİKİ İ., KAYA E., KAYNAR L., et al.

58th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), California, Amerika Birleşik Devletleri, 3 - 06 Aralık 2016, cilt.128, (Özet Bildiri)

36. THE TROUBLE THAT HEMATOLOGISTS DEALING WITH: VARICELLA-ZOSTER AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION

ÖZKAN M., OZEN I. N., DOLASIK I., KAYA E., ERKURT M. A., KUKU İ.

21st Congress of the European-Hematology-Association, Copenhagen, Danimarka, 9 - 12 Haziran 2016, cilt.101, ss.864, (Özet Bildiri)

37. USE OF ELTROMBOPAG IN IMMUNE THROMBOCYTOPENIA IN TURKEY

Cekdemir D., Ozdemirkiran F., Guvenc S., Eser A., Ozkocaman V., Sahin H. H., et al.

24th Biennial International Congress on Thrombosis / EMLTD Congress, İstanbul, Türkiye, 4 - 07 Mayıs 2016, cilt.141, (Özet Bildiri)

38. POSTTRANSPLANT 5q del SAPTANAN AKUT LENFOBLASTİK LÖSEMİ OLGUSU

ÖZKAN M., NİZAM İ., DOLAŞIK İ., KUKU İ., KAYA E., ERKURT M. A.

2. EGE HEMATOLOJİ ONKOLOJİ KONGRESİ, Türkiye, 18 - 20 Mart 2016, (Özet Bildiri)

39. BİLİNÇ BULANIKLIĞI İLE ORTAYA ÇIKAN SANTRAL SİNİR SİSTEMİNDE İNVASİF ASPERGİLLÜS ENFEKSİYONU

NİZAM İ., ERKURT M. A., KUKU İ., KAYA E., ÖZKAN M., DOLAŞIK İ., et al.

2.EGE HEMATOLOJİ ONKOLOJİ KONGRESİ, Türkiye, 18 - 20 Mart 2016, (Özet Bildiri)

40. Deri Tutulumu İle Prezente Extranodal NHL Olgu Sunumu

KUM A., ERKURT M. A., NİZAM İ., BERBER İ., KAYA E., KUKU İ., et al.

10.Ulusal Aferez Kongresi, İstanbul, Türkiye, 5 - 08 Kasım 2015, (Tam Metin Bildiri)

41. Akut Myeloid Lösemi Tanılı Hastada Nadir Bir Durum Fournier Gangreni

DOLAŞIK İ., ERKURT M. A., NİZAM ÖZEN İ., HİDAYET E., CÖMERT ÖZKAN M., KAYA E., et al.

10.Ulusal Aferez Kongresi, İstanbul, Türkiye, 5 - 08 Kasım 2015, (Tam Metin Bildiri)

42. Kadın Hastada Hemofili A

ÖZEN NİZAM İ., ERKURT M. A., KAYA E., BERBER İ., DOLAŞIK İ., CÖMERT ÖZKAN M., et al.

10.Ulusal Aferez Kongresi, İstanbul, Türkiye, 5 - 08 Kasım 2015, (Tam Metin Bildiri)

43. BÖBREK NAKLİ YAPILAN HASTALARDA ATİPİK HÜS DENEYİMİMİZ

KUM A., ÖZEN İ. N., ERKURT M. A., KAYA E., KUKU İ., BERBER İ., et al.

10. AFEREZ KONGRESİ, Türkiye, 5 - 08 Kasım 2015

44. Turgut Özal Tıp Merkezi Kemik İliği Nakli Merkezi nin 5 Yıllık Mobilizasyon Deneyimi

ÖZEN İ. N., ERKURT M. A., KAYA E., KUKU İ., BERBER İ., DOLAŞIK İ., et al.

10. ULUSAL AFEREZ KONGRESİ, Türkiye, 5 - 08 Kasım 2015, ss.50

45. İMMÜN TROMBOSİTOPENİDE STEROİDE BAĞIMLI ELTROMBOPAG YANITI

NİZAM İ., KAYA E., BERBER İ., CÖMERT ÖZKAN M., ERKURT M. A., KUKU İ.

Türk Hematoloji Derneği 41. Ulusal Hematoloji Kongresi, Türkiye, 21 - 24 Ekim 2015, ss.175

46. TROMBOTİK TROMBOSİTOPENİK PURPURA VE MYELONEKROZA NEDEN OLAN KARSİNOM

NİZAM İ., ERKURT M. A., BERBER İ., KÖROĞLU M., KAYA E., KUKU İ., et al.

TÜRK HEMATOLOJİ DERNEĞİ 41. ULUSAL HEMATOLOJİ KONGRESİ, Türkiye, 21 - 24 Ekim 2015, ss.315

47. ÜLKEMİZDE İMMÜN TROMBOSİTOPENİDE ELTROMBOPAG KULLANIMI

ÇEKDEMİR D., ÖZDEMİRKIRAN F., GÜVENÇ S., ESER A., ÖZKOCAMAN V., HAYDAROĞLU ŞAHİN H., et al.

41. Ulusal Hematoloji Kongresi, Türkiye, 21 - 24 Ekim 2015, (Tam Metin Bildiri)

48. Cytotoxic effect of benzimidazole metal complex compounds on lung cancer cells A549

APOHAN E., YEŞİLADA Ö., YILMAZ Ö., SERİNDAĞ A., YILMAZ Ü., KÜÇÜKBAY H., et al.

9th Biotechnology Congress Orlando,Florida, USA, ORLANDO, Amerika Birleşik Devletleri, 31 Ağustos - 02 Eylül 2015, (Tam Metin Bildiri) Sürdürülebilir Kalkınma

49. Gebelikte Tanı Almış ve Tedavi Edilmiş Akut Myeloid Lösemi Olgusu

MELEKOĞLU R., Eraslan S., Celik E., NİZAM İ., KAYA E.

13. Ulusal Jinekoloji ve Obstetrik Kongresi, Antalya, Türkiye, 11 - 15 Mayıs 2015, ss.537, (Özet Bildiri)

50. The cytotoxic effects of new benzimidiasol metal complex compounds on chronic myeloid leukemia cells

APOHAN E., YILMAZ Ö., YILMAZ Ü., serindağ a., YEŞİLADA Ö., KÜÇÜKBAY H., et al.

2. International Experimantal Hematology Congress, 17 - 19 Nisan 2015

51. The Clinical Characteristics and Therapeutic Outcomes of Elderly Patients with Chronic Lymphocytic Leukemia: A Retrospective Multicenter Study

Tombak A., Tiftik N., Dogu M. H., Sari I., Akay M. O., Karagulle M., et al.

56th Annual Meeting of the American-Society-of-Hematology, San-Francisco, Kostarika, 6 - 09 Aralık 2014, cilt.124, (Özet Bildiri)

52. UYGUN DONÖRLERDE ÜÇLÜ DOZ TROMBOSİT AFEREZİ DOĞU ANADOLU DAN TEK MERKEZ DENEYİMİ

ÖZGÜL M., ÖZEN İ. N., ERKURT M. A., KUKU İ., BERBER İ., DOLAŞIK İ., et al.

10.AFEREZ KONGRESİ, Türkiye, 5 - 08 Kasım 2015, (Tam Metin Bildiri)

53. Hastamın dalağı büyümüş ne yapmalıyım

KAYA E.

17. İÇ HASTALIKLARI KONGRESİ, Türkiye, 14 - 18 Ekim 2015, ss.49-52

54. Leukapheresis in elderly patients are safe and effective treatment

BERBER İ., ERKURT M. A., KUKU İ., KAYA E., NİZAM İ., GÖZÜKARA BAĞ H. G., et al.

IX. Ulusal Aferez Kongresi, Kıbrıs (Kktc), 4 - 07 Eylül 2014, ss.177-178, (Özet Bildiri)

55. Bu Cy E Conditioning Regimen Can Be An Alternative Treatment to BEAM at Autologous Transplantation for Lymphoma

ERKURT M. A., BERBER İ., NİZAM İ., KAYA E., KUKU İ.

IX. Ulusal Aferez Kongresi, Türkiye, 4 - 07 Eylül 2014

56. DEMOGRAPHICAL AND CLINICAL CHARACTERISTICS OF ELDERLY PATIENTS WITH IDIOPATHIC THROMBOCYTOPENIC PURPURA: A RETROSPECTIVE MULTICENTER STUDY

NIZAM I., TERZİ H., KORKMAZ S., KEKLİK M., KUKU İ., KAYA E., et al.

19th Congress of the European-Hematology-Association, Milan, İtalya, 12 - 15 Haziran 2014, cilt.99, ss.773, (Özet Bildiri)

57. PRIMARY BREAST LYMPHOMA IN A MALE PATIENT

BERBER İ., ERKURT M. A., yiğit a., KAYA E., KUKU İ., KÖROĞLU M., et al.

IV. INTERNATIONAL EURASIAN HEMATOLOGY CONGRESS, Antalya, Türkiye, 9 - 13 Ekim 2013, cilt.3, ss.129

58. CHRONIC MYELOİD LEUKEMIA PRESENTING A MAN WİTH A AT CHONDROPLASIA A RARE CASEINTRODUCTlON

NİZAM İ., ERKURT M. A., KAYA E., KÖROĞLU M., BERBER İ., BENTLİ R., et al.

4. INTERNATIONAL EURASIAN HEMATOLOGY CONGRESS, 9 - 13 Ekim 2013

59. AKUT MYELOİD LÖSEMİDE CİLT MUAYENESİ VE ÖNEMİ

BERBER İ., ERKURT M. A., KAYA E., NİZAM İ., KUKU İ., KÖROĞLU M., et al.

8. ULUSAL AFEREZ KONGRESİ, Kıbrıs (Kktc), 5 - 08 Eylül 2013

60. KEMİK İLİĞİ İNCELEMESİ SONRASINDA NADİR BİR KOMPLİKASYON A V FİSTÜL

BERBER İ., ERKURT M. A., BAZNA S., KAYA E., NİZAM İ., KÖROĞLU M., et al.

8. ULUSAL AFEREZ KONGRESİ, Kıbrıs (Kktc), 5 - 08 Eylül 2013, ss.149-150

61. HEMATOLOJİ KONSÜLTASYONU İSTENEN HASTALARIN BÖLÜMLERE VE İSTEM NEDENLERİNE GÖRE DAĞILIMI

KÖROĞLU M., ERKURT M. A., BERBER İ., KAYA E., KUKU İ.

38. ULUSAL HEMATOLOJİ KONGRESİ, Türkiye, 31 Ekim - 04 Kasım 2012

62. KEMİK İLİĞİ NAKİL MERKEZİ KÜLTÜR SONUÇLARIMIZ TEK MERKEZ DENEYİMİ

KÖROĞLU M., BERBER İ., KAYA E., ERKURT M. A., KUKU İ.

7. Ulusal Kemik İliği Transplantasyonu ve Kök Hücre Tedavileri Kongresi, Türkiye, 8 - 10 Mart 2012, ss.171, (Özet Bildiri)

63. radyasyon ile oluşturulan barsak hasarı üzerine Teucrium poliumun etkileri

HARPUTLUOĞLU M. M. M., DEMİREL U., BİLGİÇ Y., KAYA E., ALADAĞ M., SEÇKİN Y.

7. Ulusal Hepato Gastroenteroloji Haftası, Antalya, Türkiye, 19 - 22 Mayıs 2010, ss.35

64. Addition of Thalidomide (T) to Oral Melphalan/Prednisone (MP) in Patients with Multiple Myeloma: Initial Results of a Randomized Trial From the Turkish Myeloma Study Group.

Beksac M., Haznedar R., Firatli-Tuglular T., Ozdogu H., Aydogdu I., Konuk N., et al.

51st Annual Meeting of the American-Society-of-Hematology, Louisiana, Amerika Birleşik Devletleri, 5 - 08 Aralık 2009, cilt.114, ss.746-747, (Özet Bildiri)

65. Melatonin ve eritropoietinin deneysel inflamatuar barsak hastalığı üzerine etkileri.

Taşdemir S., PARLAKPINAR H., Vardı N., Kaya E., Acet A.

Türk Farmakoloji Derneği 20. Ulusal Farmakoloji Kongresi., Antalya, Türkiye, 1 - 02 Ocak 2009, ss.1, (Tam Metin Bildiri)

66. The effect of glycemic control on lymphocyte neural cell adhesion molecule (CD 56) expression in patients with type 2 diabetes mellitus

SENEL S., Sahin I., Kaya E., Taskapan C., AYDOGDU İ.

41st Annual Meeting of the European-Association-for-the-Study-of-Diabetes, Athens, Yunanistan, 10 - 15 Eylül 2005, cilt.48, (Özet Bildiri) Sürdürülebilir Kalkınma